Authors:
VIEL A
FORNASARIG M
NOVELLA E
GENUARDI M
CAPOZZI E
PEDRONI M
SANTAROSA M
DELEON MP
DELLAPUPPA L
ANTI M
BOIOCCHI M
Citation: A. Viel et al., LACK OF PMS2 GENE-TRUNCATING MUTATIONS IN PATIENTS WITH HEREDITARY COLORECTAL-CANCER, International journal of oncology, 13(3), 1998, pp. 565-569
Authors:
SANTAROSA M
VIEL A
DOLCETTI R
CRIVELLARI D
MAGRI MD
PIZZICHETTA MA
TIBILETTI MG
GALLO A
TUMOLO S
DELTIN L
BOIOCCHI M
Citation: M. Santarosa et al., LOW INCIDENCE OF BRCA1 MUTATIONS AMONG ITALIAN FAMILIES WITH BREAST AND OVARIAN-CANCER, International journal of cancer, 78(5), 1998, pp. 581-586
Authors:
SANTAROSA M
FAVARO D
QUAIA M
GALLIGIONI E
Citation: M. Santarosa et al., EXPRESSION OF HEAT-SHOCK-PROTEIN-72 IN RENAL-CELL CARCINOMA - POSSIBLE ROLE AND PROGNOSTIC IMPLICATIONS IN CANCER-PATIENTS, European journal of cancer, 33(6), 1997, pp. 873-877
Authors:
ZANELLI GD
QUAIA M
ROBIEUX I
BUJOR L
SANTAROSA M
FAVARO D
SPADA A
CAFFAU C
GOBITTI C
TROVO MG
Citation: Gd. Zanelli et al., PACLITAXEL AS A RADIOSENSITIZER - A PROPOSED SCHEDULE OF ADMINISTRATION BASED ON IN-VITRO DATA AND PHARMACOKINETIC CALCULATIONS, European journal of cancer, 33(3), 1997, pp. 486-492
Authors:
GALLIGIONI E
QUAIA M
MERLO A
CARBONE A
SPADA A
FAVARO D
SANTAROSA M
SACCO C
TALAMINI R
FRANCINI M
CRIVELLARI D
DIDONNA D
MAZZA G
VIGGIANO G
GALASSI P
PANIZZO R
CARMIGNANI G
FIACCAVENTO G
Citation: E. Galligioni et al., ADJUVANT IMMUNOTHERAPY TREATMENT OF RENAL-CARCINOMA PATIENTS WITH AUTOLOGOUS TUMOR-CELLS AND BACILLUS-CALMETTE-GUERIN - 5-YEAR RESULTS OF APROSPECTIVE RANDOMIZED STUDY, Cancer, 77(12), 1996, pp. 2560-2566
Authors:
GALLIGIONI E
FAVARO D
SANTAROSA M
QUAIA M
SPADA A
FRESCHI A
ALBERTI D
Citation: E. Galligioni et al., INDUCTION AND MAINTENANCE OF MONOCYTE CYTOTOXICITY DURING TREATMENT WITH LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE DESPITE TACHYPHYLAXIS TO THE CYTOKINE RESPONSE, Clinical cancer research, 1(5), 1995, pp. 493-499
Authors:
FAVARO D
SANTAROSA M
QUAIA M
SPADA A
FRESCHI A
TALMINI R
GALLIGIONI E
Citation: D. Favaro et al., SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN MELANOMA PATIENTS TREATED WITH LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE, European journal of cancer, 31A(6), 1995, pp. 1026-1027
Authors:
FAVARO D
SANTAROSA M
QUAIA M
SPADA A
FRESCHI A
TALAMINI R
GALLIGIONI E
Citation: D. Favaro et al., SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 AND SERUM CYTOKINES IN MELANOMA PATIENTS TREATED WITH LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE, Tumori, 81(3), 1995, pp. 185-190
Authors:
SANTAROSA M
FAVARO D
QUAIA M
SPADA A
SACCO C
TALAMINI R
GALLIGIONI E
Citation: M. Santarosa et al., EXPRESSION AND RELEASE OF INTERCELLULAR-ADHESION MOLECULE-1 IN RENAL-CANCER PATIENTS, International journal of cancer, 62(3), 1995, pp. 271-275
Authors:
GALLIGIONI E
SANTAROSA M
FAVARO D
SPADA A
TALAMINI R
QUAIA M
Citation: E. Galligioni et al., IN-VITRO SYNERGIC EFFECT OF INTERFERON-GAMMA COMBINED WITH LIPOSOMES CONTAINING MURAMYL TRIPEPTIDE ON HUMAN MONOCYTE CYTOTOXICITY AGAINST FRESH ALLOGENEIC AND AUTOLOGOUS TUMOR-CELLS, Tumori, 80(5), 1994, pp. 385-391
Authors:
GALLIGIONI E
QUAIA M
SPADA A
FAVARO D
SANTAROSA M
TALAMINI R
MONFARDINI S
Citation: E. Galligioni et al., ACTIVATION OF CYTOLYTIC ACTIVITY IN PERIPHERAL-BLOOD MONOCYTES OF RENAL-CANCER PATIENTS AGAINST NONCULTURED AUTOLOGOUS TUMOR-CELLS, International journal of cancer, 55(3), 1993, pp. 380-385